BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/10/2014 7:22:00 PM | Browse: 749 | Download: 491
Publication Name World Journal of Hepatology
Manuscript ID 6991
Country/Territory Denmark
Received
2013-10-31 14:04
Peer-Review Started
2013-11-01 10:27
To Make the First Decision
2014-01-08 15:03
Return for Revision
2014-01-13 10:10
Revised
2014-01-22 17:25
Second Decision
2014-02-20 20:05
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-02-20 20:19
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-03-18 14:18
Typeset the Manuscript
2014-05-08 20:32
Publish the Manuscript Online
2014-05-20 15:05
ISSN 1948-5182 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Review
Article Title Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease
Manuscript Source Invited Manuscript
All Author List Sara Heebøll, Karen Louise Thomsen, Steen B Pedersen, Hendrik Vilstrup, Jacob George and Henning Grønbæk
Funding Agency and Grant Number
Funding Agency Grant Number
Aarhus University and the Danish Council for Independent Research, Medical Sciences 11-107912
Danish Strategic Research Council 10-093499
NOVO Nordisk Foundation to Grønbæk H
Robert W to George J
Sydney Medical
University of Sydney
National Health and Medical Research Council of Australia (NHMRC) Program 1053206
National Health and Medical Research Council of Australia (NHMRC) Program 632630
National Health and Medical Research Council of Australia (NHMRC) Program 1049857
Corresponding author Henning Grønbæk, MD, PhD, Professor of Experimental Hepatology, Department of Hepatology and Gastroenterology, Aarhus University Hospital, Nørrebrogade 44, 8000 Aarhus C, Denmark. henning.gronbaek@aarhus.rm.dk
Keywords Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Steatosis; Resveratrol; AMP-activated protein kinase; Silent information regulation-2 homolog 1; Anti-oxidants; Anti-inflammatory agents; Animal studies; Clinical trial
Core Tip Henning Gr?nb?k, MD, PhD, Professor of Experimental Hepatology, Department of Hepatology and Gastroenterology, Aarhus University Hospital, N?rrebrogade 44, 8000 Aarhus C, Denmark. henning.gronbaek@aarhus.rm.dk
Publish Date 2014-05-20 15:05
Citation Heebøll S, Thomsen KL, Pedersen SB, Vilstrup H, George J, Grønbæk H. Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease. World J Hepatol 2014; 6(4): 188-198
Url http://www.wjgnet.com/1948-5182/full/v6/i4/188.htm
DOI http://dx.doi.org/10.4254/wjh.v6.i4.188
Full Article (PDF) WJH-6-188.pdf
Full Article (Word) WJH-6-188.doc
Manuscript File 6991-Review.docx
Answering Reviewers 6991-Answering reviewers.pdf
Copyright License Agreement 6991-Copyright assignment.pdf
Peer-review Report 6991-Peer review(s).pdf
Scientific Editor Work List 6991-Scientific editor work list.doc